¥5.75   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:6269.41万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:3.60亿
52周最高:8.59 52周最低:2.85 转让方式: 单位:美元
$Adverum Biotechnologies(ADVM)$
  • 还可以输入
  • 20016

Adverum Biotechnologies(ADVM) 09月20日 07时15分

新闻 Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD ADVM-022 is a unique single-administration gene therapy delivered intravitreally f ......  url.vc.watch/J94G
查看全文

Adverum Biotechnologies(ADVM) 09月19日 07时43分

新闻 Adverum to Present at Cantor Global Healthcare Conference
MENLO PARK, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy ......  url.vc.watch/JCq5
查看全文

Adverum Biotechnologies(ADVM) 09月11日 17时40分

查看全文

Adverum Biotechnologies(ADVM) 08月31日 01时16分

新闻 Adverum Biotechnologies Announces IND Active for ADVM-022, a Novel Gene Therapy to Treat Wet Age-related Macular Degeneration OPTIC Phase 1 clinical trial initiation expe ......  url.vc.watch/j38w
查看全文

Adverum Biotechnologies(ADVM) 08月25日 00时27分

新闻 Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema - ADVM-053 is a novel g ......  url.vc.watch/jjtW
查看全文

Adverum Biotechnologies(ADVM) 08月16日 03时49分

新闻 Adverum Biotechnologies Reports Second Quarter 2018 Financial Results and Provides Corporate Update
MENLO PARK, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Adverum Biotec ......  url.vc.watch/jPVQ
查看全文

Adverum Biotechnologies(ADVM) 08月06日 22时50分

新闻 Adverum Biotechnologies Appoints Katherine Bock as Vice President, Investor Relations & Corporate Communications Adverum Biotechnologies Appoints Katherine Bock as Vi ......  url.vc.watch/Ev2P
查看全文

Adverum Biotechnologies(ADVM) 08月06日 22时50分

新闻 Adverum Biotechnologies Announces Clinical Progress Across Gene Therapy Pipeline
Dosed First Patient in Cohort 3 in the ADVANCE Phase 1/2 Trial of ADVM-043 Submitted Inve ......  url.vc.watch/Ev2L
查看全文

Adverum Biotechnologies(ADVM) 07月07日 06时46分

新闻 Adverum Biotechnologies to Present at the 2018 Jefferies Global Healthcare Conference
MENLO PARK, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc ......  url.vc.watch/gvOE
查看全文

Adverum Biotechnologies(ADVM) 07月03日 04时25分

查看全文

Adverum Biotechnologies(ADVM) 06月19日 11时06分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Gasmi Mehdi
公告日:2018-06-18, 内部交易人:Gasmi Mehdi, 与发行人关系:Chief Science & Tech Officer/高管/, 操作码:A,88496(股)Common Stock; 报告日:2018-06-15, SEC Accession No. 0001209191-18-038336, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118038336/0001209191-18-038336-index.htm $Adverum Biotechnologies(ADVM)$
查看全文

Adverum Biotechnologies(ADVM) 06月19日 11时06分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Cheng Jennifer C.
公告日:2018-06-18, 内部交易人:Cheng Jennifer C., 与发行人关系:General Counsel/高管/, 操作码:A,11150(股)Common Stock; 报告日:2018-06-15, SEC Accession No. 0001209191-18-038335, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118038335/0001209191-18-038335-index.htm $Adverum Biotechnologies(ADVM)$
查看全文

Adverum Biotechnologies(ADVM) 06月19日 11时06分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:PATTERSON LEONE D
公告日:2018-06-18, 内部交易人:PATTERSON LEONE D, 与发行人关系:SVP, CFO, Interim Pres and CEO/高管/, 操作码:A,88496(股)Common Stock; 报告日:2018-06-15, SEC Accession No. 0001209191-18-038333, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118038333/0001209191-18-038333-index.htm $Adverum Biotechnologies(ADVM)$
查看全文

Adverum Biotechnologies(ADVM) 06月16日 11时07分

查看全文

Adverum Biotechnologies(ADVM) 06月16日 11时06分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Machado Patrick
公告日:2018-06-15, 内部交易人:Machado Patrick, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-31, SEC Accession No. 0001209191-18-038086, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118038086/0001209191-18-038086-index.htm $Adverum Biotechnologies(ADVM)$
查看全文

Adverum Biotechnologies(ADVM) 06月16日 11时06分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Spivey Richard N.
公告日:2018-06-15, 内部交易人:Spivey Richard N., 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-31, SEC Accession No. 0001209191-18-038066, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118038066/0001209191-18-038066-index.htm $Adverum Biotechnologies(ADVM)$
查看全文

Adverum Biotechnologies(ADVM) 06月16日 11时06分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Carter Eric G
公告日:2018-06-15, 内部交易人:Carter Eric G, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-31, SEC Accession No. 0001209191-18-038058, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118038058/0001209191-18-038058-index.htm $Adverum Biotechnologies(ADVM)$
查看全文

Adverum Biotechnologies(ADVM) 06月16日 11时06分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Woiwode Thomas
公告日:2018-06-15, 内部交易人:Woiwode Thomas, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-31, SEC Accession No. 0001209191-18-038055, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118038055/0001209191-18-038055-index.htm $Adverum Biotechnologies(ADVM)$
查看全文

Adverum Biotechnologies(ADVM) 06月16日 11时06分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Finer Mitchell H.
公告日:2018-06-15, 内部交易人:Finer Mitchell H., 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-31, SEC Accession No. 0001209191-18-038054, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118038054/0001209191-18-038054-index.htm $Adverum Biotechnologies(ADVM)$
查看全文

Adverum Biotechnologies(ADVM) 06月16日 11时06分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Cleveland Paul B
公告日:2018-06-15, 内部交易人:Cleveland Paul B, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-31, SEC Accession No. 0001209191-18-038052, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118038052/0001209191-18-038052-index.htm $Adverum Biotechnologies(ADVM)$
查看全文
  • 首页 上一页 1 2 3 下一页 尾页  每页20条/共46